Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00761917 · ClinicalTrials.gov registry record
Diagnostic Evaluation of the Tear Film
A clinical trial of Dry Eye Syndromes, sponsored by TearScience.
- Completed
- Registry status
- 229
- Enrollment target
- 8
- Study locations
NCT00761917: Completed study of Dry Eye Syndromes, sponsored by TearScience.
NCT00761917 is a study of Dry Eye Syndromes that has completed, run by TearScience. The registered enrollment target is 229 participants, below the 401-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (43% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00761917, a study of Dry Eye Syndromes, has completed, sponsored by TearScience.
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objectives of this study are to assess for a difference between normal and dry eye subjects in tear film quality using a diagnostic interferometry device and to determine whether there are associations between tear film quality and dry eye symptoms and signs.
Conditions Studied
Interventions
- DEVICE Tear Film Analyzer
Study Locations (8)
North Carolina
- - Charlotte
- - Henderson
Arkansas
- - Fayetteville
Georgia
- - Morrow
Illinois
- - Oak Lawn
Kentucky
- - Edgewood
Minnesota
- - Bloomington
Missouri
- - Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-11 |
What the finished NCT00761917 record still lists
NCT00761917 is an observational study that tracks outcomes without assigning an intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap, below the 401-participant average among 17 other Dry Eye Syndromes trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Tear Film Analyzer is the first listed.
NCT00761917 lists 8 locations in 7 states (North Carolina, Arkansas, Georgia).
Frequently Asked Questions
What is clinical trial NCT00761917 about?
NCT00761917 is a clinical study titled "Diagnostic Evaluation of the Tear Film". The objectives of this study are to assess for a difference between normal and dry eye subjects in tear film quality using a diagnostic interferometry device and to determine whether there are associations between tear film quality and dry eye symptoms and signs.
What is the current status of trial NCT00761917?
This trial is currently completed. The enrollment target is 229 participants. The study started on 2008-06. Estimated completion is 2008-11.
What conditions does trial NCT00761917 study?
This clinical trial studies the following conditions: Dry Eye Syndromes.
What interventions are being tested in trial NCT00761917?
The interventions under investigation include: Tear Film Analyzer (DEVICE).
Who is sponsoring clinical trial NCT00761917?
This trial is sponsored by TearScience, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00761917 being conducted?
This trial has 8 study locations across Arkansas, Georgia, Illinois, Kentucky, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00761917's enrollment target sits among peer trials
229 4th of 17 higher than 14 of 17 other Dry Eye Syndromes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Syndromes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
ACTIVE NOT RECRUITING · NA
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
COMPLETED · NA
-
TrueTear in Sjogren's Disease Patients
COMPLETED · NA
-
ACCURATE Study for Subjects With Dry Eyes
COMPLETED · Phase 4
-
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia